(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ACTIFOCUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ACTIFOCUS

ST13

US500000088656767

Class

1, 3, 5, 40

Filing

88656767

Registration

6564978

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

11/23/2021

Trademark type

Word

Nice classes

1, 3, 5, 40

Filing date

10/16/2019

Registration date

11/23/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/23/2021

Last transaction

11/23/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Minato-ku, Tokyo, JP

Examiner

OAKES, ANNA JENNIE

Law office

L30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

F. C. (pessoa física)

Representatives

Suzanne M. Hengl BAKER BOTTS L.L.P.

Technical classification

Nice Classes

Class 1Class 3Class 5Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical preparations for scientific purposesother than for medical or veterinary use; industrial chemicals; Chemicals for use in industry and science; chemical compositions for developingprinting and enlarging photographs; plant growth regulating preparations; fertilizers; Fatty acids used in the manufacture of pharmaceutical and cosmetic products; Liposomes used in the manufacture of pharmaceutical and cosmetic products; Chemicals additivesliposomes for use in the manufacture of pharmaceutical and cosmetic products; antibodies for in vitro scientific or research use; antibodies used in analyzing and detecting certain toxins or diseases for laboratory or research use; anti cancer nucleic acid for laboratory use; anti aging nucleic acid for laboratory use; anti-inflammatory nucleic acid for laboratory use; anti cancer peptide for laboratory use; anti aging peptide for laboratory use; anti-inflammatory peptide for laboratory use; anti cancer compounds for laboratory use; anti aging compounds for laboratory use; anti-inflammatory compounds for laboratory use; compounds used for analysis of angiogenesisother than for medical or veterinary use; cells for laboratory useother than for medical or veterinary use; liposome use for transfection of cells for scientific or research use; Chemical reagentsother than for medical or veterinary purposes

Class 3

Cosmetics; skin soap; bath soap; deodorant soap; dishwasher detergents; laundry detergents; detergents for household use; dentifrices; fragrances and perfumery; essential oils for flavoring food and beverages; incense

Class 5

Liposome for use in medical pharmaceutical preparations; Drug delivery agents in the form of liposomes that facilitate the delivery of pharmaceutical preparations and nucleotides; Drug delivery agents in the form of capsules that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of microcapsules composed of liposomes for the delivery of pharmaceutical preparations and nucleotides; liposome preparations for use in the delivery and release of pharmaceutical preparations; liposome reagents for transfection of cellsonly for medical and veterinary use; dietary supplements; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; dietary supplements for animals; antibodies for use in disease testing and pathology diagnosis

Class 40

Processing of liposome pharmaceutical preparations composed of nucleotides; processing of liposome preparations composed of nucleotides; processing of pharmaceutical preparations for drug delivery system composed of liposomes for delivering nucleotides; processing of microcapsules for drug delivery system composed of liposomes for delivering nucleotides; processing of chemicals for drug delivery system composed of liposomes for delivering nucleotides; custom manufacture and processing of pharmaceuticals and chemicals for others; custom manufacture and processing of cosmetics and soaps for others

Publications

History of USPTO decisions and trademark events.

31 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

11/23/2021

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/19/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/19/2021

IUCN

NOTICE OF ALLOWANCE CANCELLED

10/05/2021

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

10/05/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/03/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/08/2021

PUBO

PUBLISHED FOR OPPOSITION

06/08/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/19/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/03/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/29/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/29/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/26/2021

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/01/2021

GNSL

LETTER OF SUSPENSION E-MAILED

02/01/2021

CNSL

SUSPENSION LETTER WRITTEN

02/01/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/25/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/25/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/22/2021

DOCK

ASSIGNED TO EXAMINER

08/31/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

07/23/2020

GNSI

INQUIRY TO SUSPENSION E-MAILED

07/23/2020

CNSI

SUSPENSION INQUIRY WRITTEN

07/23/2020

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

07/18/2020

ALIE

ASSIGNED TO LIE

06/29/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

12/05/2019

GNSL

LETTER OF SUSPENSION E-MAILED

12/05/2019

CNSL

SUSPENSION LETTER WRITTEN

12/05/2019

DOCK

ASSIGNED TO EXAMINER

12/03/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/20/2019

NWAP

NEW APPLICATION ENTERED

10/19/2019

Continuous trademark protection

Get notified about every new filing that threatens ACTIFOCUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.